InsidersTradesSigma
Track the Ocumension Therapeutics - B stock price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares are quoted on the HK market, under the supervision of HKEX. Operating in the Health Care sector, Ocumension Therapeutics - B has recorded 2 insider filings. Market capitalisation: €4.1bn. The latest transaction was filed on 1 April 2026 (Sale). Among the most active insiders: Hu Zhaopeng. Every trade is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ocumension Therapeutics - B Buy (bullish), based on 2 analysts. Average price target: HK$9.56.
4Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,928 of 29,062 companies
26.1
score / 100
Value20
Quality32
FCF yld-8.6%
Earn yld-3.8%
EV/EBITDA·
ROE-4.3%
Gross mgn45%
Net mgn-20%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 April 2026
Declarations2 total
1,072 sharesShareXHKGHKEX:DA20260401E00038
13,700 sharesShareXHKGHKEX:DA20260401E00037
2 of 2 declarations
About Ocumension Therapeutics - B
Ocumension Therapeutics - B is a company focused on developing innovative treatments for eye diseases. It is listed on the Hong Kong Stock Exchange (XHKG).